Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Mifepristone as Adjunctive Therapy in Alzheimer's Disease

ClinicalTrials.gov ID: NCT00105105

Public ClinicalTrials.gov record NCT00105105. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 12:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Placebo-controlled Trial of the Safety and Efficacy of C-1073 (Mifepristone) as Adjunctive Therapy in Alzheimer's Disease

Study identification

NCT ID
NCT00105105
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Corcept Therapeutics
Industry
Enrollment
160 participants

Conditions and interventions

Interventions

  • Mifepristone Drug

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2003
Primary completion
Oct 31, 2005
Completion
Oct 31, 2005
Last update posted
Dec 10, 2009

2003 – 2005

United States locations

U.S. sites
21
U.S. states
10
U.S. cities
20
Facility City State ZIP Site status
Pivotal Research Center Mesa Arizona 85210
Pivotal Research Center Peoria Arizona 85381
ATP Clinical Trials Fountain Valley California 92708
UCI Irvine Medical Center Orange California 92868
California Neuroscience Research Medical Group, Inc. Sherman Oaks California 91403
AVI Clinical Research Torrance California 90505
Baumel-Eisner Neuromed Inst Boca Raton Florida 33486
Baumel-Eisner Neuromed Inst Fort Lauderdale Florida 33321
Clinical Physiology Associates Fort Myers Florida 33916
Baumel-Eisner Neuromed Inst Miami Beach Florida 33154
Stedman Clinical Trials Tampa Florida 33613
Johnnie B. Byrd, Sr. Alzheimer's Center & Research Inst Tampa Florida 33647
Memory Enhancement Center Long Branch New Jersey 07740
Eastside Medical Research New York New York 10021
Neuro Center of Ohio Toledo Ohio 43623
Pahl Pharmaceutical Research, LLC Oklahoma City Oklahoma 73118
Clinical Pharmaceutical Trials, Inc. Tulsa Oklahoma 74104
Clinical Trials Research Services Pittsburgh Pennsylvania 15206
Grayline Clinical Drug Trials Wichita Falls Texas 76309
International Clinical Research Associates Richmond Virginia 23229
International Clinical Research Associates Virginia Beach Virginia 23452

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00105105, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 10, 2009 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00105105 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →